Akèy › Timè stromal gastro-intestinal › Nebraska › Omaha
Etid klinik pou Timè stromal gastro-intestinal nan Omaha, NE
5 etid pou Timè stromal gastro-intestinal ap chèche patisipan nan sit nan ak bò kote Omaha (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
Ap rekriteFaz 3
- GSK Investigational Site, Omaha
A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)
Ap rekriteFaz 3
- GSK Investigational Site, Omaha
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Ap rekriteFaz 2
- Nebraska Cancer Specialists - Midwest Cancer Center - Legacy, Omaha
Integrated Cancer Repository for Cancer Research
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Methodist Estabrook Cancer Center, Omaha
- Nebraska Methodist Health System, Omaha
- University of Nebraska Medical Center, Omaha
- ak 1 plis
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
Ap rekriteFaz 3
- Nebraska Methodist Hospital, Omaha
Etid Timè stromal gastro-intestinal nan lòt vil
- Miami, FL8 etid
- New York City, NY7 etid
- Boston, MA7 etid
- Philadelphia, PA6 etid
- Houston, TX6 etid
- San Diego, CA5 etid
- Portland, OR5 etid
- Nashville, TN5 etid
- Durham, NC4 etid
- Rochester, MN4 etid
- Ann Arbor, MI4 etid
- Los Angeles, CA4 etid
Lòt etid nan Omaha
- Kansè pwostat27 etid
- Kansè Poumon ki pa ti selil24 etid
- Kansè nan tete22 etid
- Kansè (tout kalite)18 etid
- Kansè kolorektal18 etid
- Myelom Miltip16 etid
- Kansè ovè14 etid
- Limfòm Non-Hodgkin14 etid
- Kansè pankreyas14 etid
- Kansè Metastatik13 etid
- Karsinòm selil skuamèz tèt ak kou13 etid
- Ensifizyans kadyak13 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.